Found: 22
Select item for more details and to access through your institution.
Real‐world outcomes with immunosuppressive therapy for aplastic anemia in patients treated at the University of Michigan.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 3, p. 424, doi. 10.1111/ejh.14131
- By:
- Publication type:
- Article
Utility of methicillin‐resistant Staphylococcus aureus (MRSA) nasal screening in patients with acute myeloid leukemia (AML).
- Published in:
- Transplant Infectious Disease, 2021, v. 23, n. 4, p. 1, doi. 10.1111/tid.13612
- By:
- Publication type:
- Article
Late Responses in Patients With Chronic Myeloid Leukemia Initially Refractory to Tyrosine Kinase Inhibitors.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 1, p. 17, doi. 10.1016/j.clml.2021.07.001
- By:
- Publication type:
- Article
Propensity-score Matched Comparison of Salvage Chemotherapy Regimens in Relapsed/Refractory Acute Myeloid Leukemia.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Integrative Sequencing of Myeloproliferative Neoplasms.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S358, doi. 10.1016/j.clml.2019.07.379
- By:
- Publication type:
- Article
SOHO State of the Art Updates and Next Questions: Myelofibrosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Genomic Landscape and Clinical Features of Triple-Negative Myelofibrosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S268, doi. 10.1016/j.clml.2018.07.187
- By:
- Publication type:
- Article
Defining and Treating Older Adults with Acute Myeloid Leukemia who Are ineligible for intensive Therapies.
- Published in:
- Frontiers in Oncology, 2015, p. 1, doi. 10.3389/fonc.2015.00280
- By:
- Publication type:
- Article
Non-Pharmacologic Management of Splenomegaly for Patients with Myelofibrosis: Is There Any Role for Splenectomy or Splenic Radiation in 2020?
- Published in:
- Current Hematologic Malignancy Reports, 2020, v. 15, n. 5, p. 391, doi. 10.1007/s11899-020-00598-x
- By:
- Publication type:
- Article
Novel Therapies for Myelofibrosis.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 6, p. 611, doi. 10.1007/s11899-017-0403-0
- By:
- Publication type:
- Article
Mini-HCVD plus inotuzumab plus or minus blinatumomab: Hype or hope?
- Published in:
- 2019
- By:
- Publication type:
- letter
Quantitative MRI reveals heterogeneous impacts of treatment on diseased bone marrow in a mouse model of myelofibrosis.
- Published in:
- Magnetic Resonance in Medicine, 2024, v. 91, n. 6, p. 2568, doi. 10.1002/mrm.30016
- By:
- Publication type:
- Article
Real world use of FLT3 inhibitors for treatment of FLT3+ acute myeloid leukemia (AML): A single center, propensity-score matched, retrospective cohort study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 6, p. 1315, doi. 10.1177/10781552211020815
- By:
- Publication type:
- Article
Successful use of blinatumomab in a patient with acute lymphoblastic leukemia and severe hepatic dysfunction.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 1, p. 200, doi. 10.1177/1078155219829534
- By:
- Publication type:
- Article
Exploring Adolescent and Young Adult Cancer Survivors' Experience with Cancer Treatment-Related Symptoms: A Qualitative Analysis of Semi-Structured Interviews.
- Published in:
- Journal of Adolescent & Young Adult Oncology, 2024, v. 13, n. 4, p. 665, doi. 10.1089/jayao.2024.0053
- By:
- Publication type:
- Article
Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemia.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 6, p. 682, doi. 10.1007/s12185-023-03670-3
- By:
- Publication type:
- Article
Exploring the Molecular Landscape of Myelofibrosis, with a Focus on Ras and Mitogen-Activated Protein (MAP) Kinase Signaling.
- Published in:
- Cancers, 2023, v. 15, n. 18, p. 4654, doi. 10.3390/cancers15184654
- By:
- Publication type:
- Article
A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia.
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, p. 1, doi. 10.1186/s13045-017-0550-8
- By:
- Publication type:
- Article
Evaluating the efficacy and toxicity of dose adjusted pegylated L-asparaginase in combination with therapeutic drug monitoring.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 11, p. 3133, doi. 10.1007/s00277-023-05373-5
- By:
- Publication type:
- Article
Oncology stewardship in acute myeloid leukemia.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 8, p. 1627, doi. 10.1007/s00277-022-04872-1
- By:
- Publication type:
- Article
The leukemia strikes back: a review of pathogenesis and treatment of secondary AML.
- Published in:
- Annals of Hematology, 2019, v. 98, n. 3, p. 541, doi. 10.1007/s00277-019-03606-0
- By:
- Publication type:
- Article
Efficacy and Safety of Pacritinib vs Placebo for Patients With Severe COVID-19: A Phase 2 Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 12, p. e2242918, doi. 10.1001/jamanetworkopen.2022.42918
- By:
- Publication type:
- Article